ClinActis

What ClinActis does

ClinActis Pte. Ltd. is a Singapore-headquartered, full-service contract research organization (CRO) founded in 2009 that delivers clinical trial services exclusively across the Asia Pacific region. The company serves pharmaceutical, biotechnology, medical device, and medical nutrition sponsors — particularly US-based and European sponsors seeking to expand trials into APAC — and has completed more than 150 clinical projects across Phase I-IV for over 50 sponsors since inception.

ClinActis operates a regional footprint spanning 12 countries (Singapore, South Korea, China, Taiwan, Hong Kong, Philippines, Malaysia, Thailand, Japan, India, Australia, and New Zealand) with wholly-owned subsidiaries in Singapore, Malaysia, Hong Kong, the Philippines, and Australia, and branch offices in South Korea and Taiwan. Service offerings span the full clinical trial lifecycle: drug development strategy, clinical project management, site management, locally-staffed clinical monitoring, data management and biostatistics, medical writing, regulatory consulting, and Functional Service Provider (FSP) staffing. The underlying technology stack is conventional CRO enterprise software — Oracle Clinical/EDC and Oracle Argus Safety, LORENZ docuBridge for eCTD, SAS and nQuery for biostatistics, and SharePoint-Montrium — with SOPs compliant with ICH-GCP standards. There is no disclosed proprietary AI/ML capability.

Revenue is generated on a project-based, professional services model with custom quote-based pricing tied to study phase, therapeutic area, country scope, and service mix, typically under multi-year contracts. Go-to-market is direct enterprise sales led by senior management and a dedicated business development team (including UK-based Director of Business Development for European and US sponsor outreach), supplemented by industry conference presence, content marketing, and webinars. For multinational trials, ClinActis operates within a six-CRO consortium that extends geographic coverage into North America, Europe, Central Eastern Europe, Africa, and Latin America without M&A. The company is privately held with no disclosed funding rounds, no parent company, and no public listing.

Name

ClinActis

Legal name

ClinActis Pte. Ltd.

Website

https://clinactis.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

ClinActis is a Singapore-based, full-service CRO founded in 2009 that delivers Phase I-IV clinical trial services exclusively across 12 Asia Pacific countries to pharmaceutical, biotech, medical device, and medical nutrition sponsors globally.

Ownership category

akta.pro rank

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Project Management Services: Full-service clinical research services including project management, site management, clinical monitoring, data management and biostatistics, medical writing, and consulting services for Phase I-IV clinical trials in APAC.
2. Functional Service Provider (FSP) and Temporary Clinical Staffing: Providing specialized clinical research personnel including CRAs, project managers, regulatory affairs specialists, data managers, SAS programmers, medical writers, and quality assurance professionals on a project or FSP basis.
3. Regulatory Consulting Services: Consulting support for protocol design, clinical regulatory submissions including INDs, NDAs, and regulatory agency interactions, statistical support, and regulatory submissions for FDA, EMA and APAC regulatory bodies.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

ClinActis is a full-service Contract Research Organization (CRO) that delivers clinical trial services exclusively across the Asia Pacific region. Its core offering is end-to-end clinical research project management for pharmaceutical, biotechnology, medical device, and medical nutrition sponsors — including drug development strategy consulting, project management, site management, locally-based clinical monitoring, data management and biostatistics, medical writing, and regulatory consulting, all delivered under ICH-GCP standards with country-specific local expertise.

Product overview

ClinActis is a full-service Contract Research Organization (CRO) providing comprehensive clinical trial services exclusively in the Asia Pacific (APAC) region. The company offers a unified portfolio of integrated services spanning the entire clinical trial lifecycle: Drug Development Strategy in Asia Pacific (strategic consulting), Clinical Project Management, Site Management, Clinical Monitoring, Data Management & Biostatistics, Medical Writing, Consulting Services, and Functional Service Provider (FSP) Temporary Clinical Staffing. All services are delivered by locally-based teams with deep regional expertise, ensuring compliance with both international ICH-GCP standards and country-specific regulatory requirements across APAC.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Development Strategy in Asia Pacific Strategic consulting service that helps sponsors select the optimal approach for drug development in the APAC region, considering study phase, therapeutic area, and client objectives for clinical development.
• Clinical Project Management End-to-end project management services for clinical trials, with experienced project managers overseeing study design, protocol development, site selection, project planning and execution.
• Site Management Site identification, activation, and ongoing management including feasibility assessments, site selection, initiation visits, regulatory and ethics submissions, and on-site monitoring visits.
• Clinical Monitoring Locally-based CRA assignment in each country where trials are conducted, with deep knowledge of local regulatory requirements, cultural nuances, and healthcare systems for effective site monitoring.
• Data Management & Biostatistics Comprehensive data management and biostatistics services spanning preclinical development guidance through regulatory filings and post-marketing studies, using SOPs compliant with ICH and GCP standards and validated Oracle EDC, SAS, and nQuery systems.
• Medical Writing Medical writing services covering protocol development, clinical study reports, regulatory documents, investigator brochures, safety reports, and regulatory submissions including INDs, NDAs, and PMAs.
• Consulting Services Ad-hoc consulting services including protocol design, clinical regulatory support, statistical support, and regulatory submission assistance for IND/NDA processes with FDA, EMA, and APAC regulatory bodies.
• Functional Service Provider (FSP) and Temporary Clinical Staffing Flexible staffing solutions providing experienced clinical research professionals across functions including clinical operations, medical, regulatory, pharmacovigilance, medical writing, data management, SAS programming, and quality assurance on a project or FSP basis.

Quantifiable outcome

• Access to large diverse patient populations across APAC for faster recruitment
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• ClinDatrixcoreStrategic or Co-development Partner · 16 May 2014ClinActis joined a consortium of six CROs from around the world to offer services for multinational clinical trials. ClinDatrix, headquartered in Irvine, California, covers the United States and Canada. The collaboration enables ClinActis to offer sponsors the services of a large CRO with local proximity and personalized attention, while providing access to North American expertise and clinical research technology including EDC, eCTD, and Oracle Argus safety systems.
• DOKUMEDS SIAcoreStrategic or Co-development Partner · 16 May 2014DOKUMEDS supports clinical trials in Central Eastern Europe from operations in Latvia, Lithuania, Estonia, Ukraine, Russia, Poland and Romania. The partnership provides ClinActis clients access to key opinion leaders and clinical sites in Central Eastern Europe, a region of growing interest to pharmaceutical and biotechnology companies.
• DOT InternationalcoreStrategic or Co-development Partner · 16 May 2014DOT International, based in Tokyo, covers Japan for clinical trial services. The partnership is particularly valuable for sponsors targeting the Japanese market, which has the world's second largest pharmaceutical market with growing healthcare needs. DOT provides regulatory negotiation, clinical development plan consultation, and trial management support in China as well.
• OnQ Research PTY LTDminorStrategic or Co-development Partner · 16 May 2014OnQ Research serves African clinical sites from its headquarters in South Africa. The partnership adds geographic scale for early-stage sponsors at cost-effective fees and provides ClinActis with expanded African coverage through a firm involved in over 120 clinical trials.
• Research & Development RA S.A.minorStrategic or Co-development Partner · 16 May 2014Research & Development RA S.A., based in Buenos Aires, Argentina, covers Central and South America for clinical research services. The partnership enables ClinActis to present comprehensive multinational proposals at the proposal stage rather than seeking resources after winning work, strengthening bids and adding transparency.
• Venn Life SciencescoreStrategic or Co-development Partner · 16 May 2014Venn Life Sciences serves European clinical sites from its headquarters in Ireland with offices in England, France, Germany and the Netherlands. The partnership enables ClinActis to better support clients' needs and secure larger and later stage studies, with Venn celebrating 25 years in business in 2014.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Regional players

• Linical: Japan-headquartered CRO with growing Asia Pacific and US operations providing Phase I–IV services. Comparable as a Japan-anchored regional peer operating in similar APAC therapeutic areas and competing for Japanese pharma-sponsored multinational trials.

Broad incumbents

• Syneos Health: Global biopharmaceutical services organization providing clinical development and commercialization services with APAC presence. Comparable as a broad incumbent full-service CRO serving pharma and biotech sponsors on multinational trials.
• Parexel International: Global CRO with significant Asia Pacific infrastructure delivering Phase I–IV clinical development, biostatistics, regulatory, and pharmacovigilance services. Comparable as a broad incumbent competing for the same multinational sponsor RFPs.
• ICON plc: Global CRO providing Phase I–IV clinical research services across all major geographies including APAC. Comparable as a broad incumbent offering the same full-service portfolio that large pharma sponsors commonly consolidate onto.
• Labcorp Drug Development (Fortrea): Global clinical development services organization (spun out from Labcorp) with deep Asia Pacific operations across Phase I–IV and central labs. Comparable as a broad incumbent competing for the same full-service CRO engagements.
• IQVIA: The largest global CRO and life sciences services firm with extensive Asia Pacific operations across clinical, data, and technology. Comparable as the dominant full-service competitor whose APAC expansion directly threatens mid-size specialists.

Emerging players

• Worldwide Clinical Trials: Mid-size global CRO focused on complex Phase II–III trials across multiple therapeutic areas including oncology, CNS, and rare disease. Comparable as a similarly sized full-service CRO pursuing mid-size biotech sponsors with multinational scope.

Direct peers

• Novotech: Australia-headquartered full-service CRO focused primarily on the Asia Pacific region, serving biotech and pharma sponsors with Phase I–IV services. The closest pure-play comp to ClinActis given the shared APAC exclusivity, sponsor base, and service portfolio.
• CMIC Group: Japan's largest CRO offering clinical trial services across Asia including site management, monitoring, data management, and biostatistics. Directly comparable as a regional APAC CRO serving pharma and medical device sponsors with Phase I–IV capabilities.
• EPS Holdings: Japan-based clinical research and CRO services group with operations across Asia, providing CRO, site management, and SMO services. Comparable mid-size APAC CRO competing for similar Japanese and Asian trial sponsors.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ClinActis
• LinkedInlinkedin.com/company/clinactis

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ClinActis